us market start modestli higher follow posit employ data gain pace session progress major indic continu
trade elev level close near session peak crude gold declin within technolog stock rule
paw tax reform rais estim
clariti tax reform kicker consist initi analysi pursuant tax cut job act experi
basi point reduct effect tax rate vs previou estim
exclud tax reform anticip one-tim million headwind deem repatri foreign profit
net remeasur defer tax asset liabil view disclosur clariti posit
consequ rais ep estim
lower corpor tax run rate lower ep
aforement one-tim charg note previous estim ep accret tax reform outer year
assum offset latest disclosur thu rel line preliminari analysi
reiter outperform remain posit bias head upcom investor industri confer
 vmx feb well earn releas feb view lead dog nostic innov
well posit robust fundament backdrop increment driver pipelin grow instal base
geograph expans tax reform add anoth posit element previous note see note
road manag addit cash flow like util support continu share repurchas contribut
five-year ep growth rate pursuant preciou guidanc risk includ shift fundament
shrewd move rdc final close acquisit two jackup initi auction may price
per jack-up look steal even adjust reactivation/upgrad rig requir go
back work upgrad deal price still point discount jack-up sale around
kick tire low ball price look primarili function rdc one bidder show
auction brazil last may lot potenti deal driller strategi rdc
discount shopper like manag said way gener excess return invest counter-cycl agre
rdc know rig built pbr use letourneau expect rig
either use renew rdc retir jackup downcycl potenti attract
opinion sold aro jv aramco would acceler aro growth could struck attract term
aro rdc given bargain basement purchas price
buyer market complet deal come heel recent acquisit privat investor harsh
environ floater west rigel purchas point roughli discount newbuild
price expect one-off sale purchas transact ink activ continu stabil
analyst disclosur credit suiss seek busi compani cover research
report result investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest
weekli ocaliva tracker updat script due christma holiday
ocaliva total prescript week end week-over-week new prescript nrx
new-to-brand prescript nbrx updat monday last report week-over-
week trx nrx fell across drug due christma holiday nbrx increas includ impact
christma holiday script volatil product move launch
dear doctor fda safeti updat watch script close come week see
recoveri continu think share trade near term around script trend watch trend
close script trend remain resili feel would serv mitig concern strength shown
past week seem ocaliva start shake-off safeti letter warn overhang get back prior level
though prescript still trend compar past month averag magnitud lesser
tracker project us ocaliva sale vs model estim consensu full
year tracker estim us sale vs model estim consensu
extrapol sale project fy took histor week averag nbrx rate appli
subsequ week year assumpt tracker includ nbrx weekli run rate weekli
dropout rate annual im captur rate gross net lower
subsequ quarter price increas think assumpt conserv side adjust
accordingli get clariti script trend
new year new tax new frontier renew start year strong storag off-shore wind target ny better
fear tax reform favor solar tariff china still come trade case uncertainti
empir strike storag requir ny state establish energi storag target governor cuomo announc
week materi acceler previou plan gw current support small pilot
program within ed rateplan new target would go includ
commit like either loan guarante low-cost debt via ny green bank pilot project
state energi research develop author nyserda gw energi storag produc
energi valu batteri storag deliv low-cost clean renew gener peak hour therebi avoid
need costli convent gas-fir peaker plant link report announc live ny
off-shore wind storag link report declin cot batteri energi storag idea engin batteri
off-shore awaken ny state also target instal gw off-shore wind plan auction mw
solicit could present new opportun es off-shore wind develop partnership
danish develop rsted a/ alreadi submit bid off-shore rfp interestingli
bid also includ mw batteri storag coupl project gov baker sign clean
energi mandat requir distribut compani solicit year contract off-shore wind overal
countri gw project earli plan stage one mw project oper near ri
solar ppa worri trade case austin energi announc solar ppa intersect power
annual year util receiv competit bid separ project deal impli
averag ppa period low ppa price come amidst uncertainti potenti tariff
pend section trade case like plant expect start oper
receiv product pleas specifi credit suiss contact email call
take util look fairli valu nearli under-perform sinc mid-novemb see regul group
trade discount price-to-earnings broader appropri valu consid
histor correl yield appli discount expect rel impact tax reform
sector vs other rotat understand given rise rate environ continu note cs
forecast still yearend util continu enjoy strong yield support remain
ultra-low environ continu emphas integr regul includ top pick
view pullback nuclear subsidi challeng opportun
nj nuclear subsidi tabl regular session jan variou media cite sourc familiar matter
report bill introduc nj senat offer payment nuclear plant form nuclear divers credit
ndc would place state assembl agenda vote like come vote lame-
duck session prior incom gov murphi take offic jan last lame-duck session would jan
still possibl bill could vote although think regular session later year
like oppon bill busi consum advoc gas-gener rais concern nj bureau
public util bpu author subsidi although prior analysi decemb conclud bpu
would fact discret reduc amount charg
im tracker week end decemb
iqvia week announc supplier previou restrict volum azn calquenc releas
calquenc btk inhibitor receiv acceler approv fda mantl cell lymphoma octob
rare aggress b-cell lymphoma launch chart show calquenc well imbruvica abbvie/jnj
market lead btk inhibitor mcl/cll lymphoma alongsid venclexta roche/abbvi inhibitor
approv cll delet posit result broad cll zydelig gilead inhibitor
number lymphoma highlight first indic small popul new case diagnos
us year illustr limit scrip far howev head-to-head studi imbruvica
elev high risk cll due report cs forecast sale calquenc mantl
cell well small indic peak sale forecast cll post po imbruvica peak
sale expect reach
question manag team
new year upon us sever investor industri confer approach compil list relev
question topic discuss respect manag team across divers coverag univers healthcar
technolog distribut compani includ follow sub-sector pbms/pharmaci distributor contract
servic organ clinic laboratori anim health dental hcit life scienc among other pleas reach
team excel-bas copi latest model request prepar meet
headlin price previou day close unless otherwis note
compani mention price jan
receiv product pleas specifi credit suiss contact email call
analyst identifi report certifi respect compani secur individu analyz
view express report accur reflect person view subject compani secur
part compens directli indirectli relat specif recommend
view express report
analyst respons prepar research report receiv compens base upon variou factor includ
credit suiss total revenu portion gener credit suiss invest bank activ
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel
analyst coverag univers consist compani cover analyst within relev sector outperform
repres attract neutral less attract underperform least attract invest opportun
octob canadian well european rate base stock total return rel
analyst coverag univers consist compani cover analyst within relev sector outperform
repres attract neutral less attract underperform least attract invest opportun
latin american asia stock exclud japan australia rate base stock total return rel
averag total return relev countri region benchmark india bse sensex index prior octob
 canadian rate base stock absolut total return potenti current share price
rel attract stock total return potenti within analyst coverag univers australian new zealand
stock expect total return calcul includ roll dividend yield outperform rate assign
greater equal under-perform less equal neutral may
assign overlap rate rang allow analyst assign rate put
context associ risk prior may rang outperform under-perform rate
overlap neutral threshold oper juli
restrict certain circumst credit suiss polici and/or applic law regul preclud certain type
commun includ invest recommend cours credit suiss engag invest
bank transact certain circumst
volatil indic stock defin volatil stock price move month
least past month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect
fundament and/or valuat sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cover
credit suiss distribut stock rate bank client
purpos nyse nasd rate distribut disclosur requir stock rate outperform neutral under-perform
